Ocugen Provides Business Update and Second Quarter 2021 Financial Results
Conference Call and Webcast Today at 8:30 a.m. ET
- Rolling regulatory submission to Health Canada completed and review process initiated; U.S. FDA talks continue
- Multiple milestones achieved across regulatory and supply chain to support potential commercialization…
